Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$26.48
00.00%
At close: Sep 19, 4:00 PM EDT
$26.48
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Overview Rating
Speculative
Genmab (NASDAQ:GMAB) Stock Quotes, Forecast and News Summary
Genmab Stock (NASDAQ: GMAB) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 596.59K |
| Day Range | - - - |
| 52 Wk Range | 24.53 - 37.97 |
| Market Cap | $16.82B |
| P/E Ratio | 21.04 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 42 |
| Short Interest | 0.34% |
| Days to Cover | 5.08 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Genmab
Sector
Health Care
Industry
Biotechnology
Genmab AS is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the ...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Genmab (GMAB) stock?
You can purchase shares of Genmab (NASDAQ:GMAB) through any online brokerage.
Who are Genmab (GMAB) competitors?
Other companies in Genmab’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
What is the forecast, or price target, for Genmab (GMAB) stock?
Genmab has a consensus price target of $40.56.
What is the current price for Genmab (GMAB)?
The stock price for Genmab (NASDAQ: GMAB) is $26.48 last updated September 19, 2024 at 4:00 PM EDT.
Does Genmab (GMAB) pay a dividend?
There are no upcoming dividends for Genmab.
When is Genmab (NASDAQ:GMAB) reporting earnings?
Genmab’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
Is Genmab (GMAB) going to split?
There is no upcoming split for Genmab.
What sector and industry does Genmab (GMAB) operate in?
Genmab is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.